Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Amoxapine

U.S. FDA Requirements: Amoxapine

Pharmaceutical / Drug Definition : Inhibits reuptake of norepinephrine or serotonin at presynaptic neuron, thereby increasing levels of these neurotransmitters in brain. Also has sedative, anticholinergic, and mild peripheral vasodilatory properties.

In the United States, Amoxapine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Amoxapine.

Registrar Corp assists Amoxapine companies with:

  • FDA Registration Amoxapine
  • FDA Listing Amoxapine
  • FDA Label Requirements and Exceptions Amoxapine
  • FDA Import Information Amoxapine
  • FDA Detentions Amoxapine (Amoxapine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Amoxapine (Amoxapine Suppliers)
       - Processors Amoxapine
       - Repackers Amoxapine
       - Relabelers Amoxapine
       - Exporters Amoxapine
       - Importers Amoxapine
For more information about Amoxapine, simply click below:

Live Help

U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207

Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2017 Registrar Corp
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco